We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NNDM:NASDAQNano Dimension Ltd. Analysis

Data as of 2026-06-12 - not real-time

$1.49

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Nano Dimension (NNDM) is trading at $1.49, well below its 20‑day, 50‑day and 200‑day moving averages of 1.61, 1.69 and 1.70, signaling a bearish technical backdrop. The RSI of 38.7 and a bearish MACD histogram further underscore short‑term downside pressure, while the price sits just above the identified support of $1.44 and far from the resistance at $1.85. Fundamentally, the company posts a modest revenue growth of 6.4% but suffers deep operating losses (‑70% operating margin) and a negative EPS of ‑$0.68, resulting in a forward P/E of 149 and a price‑to‑book of 0.64. Despite a hefty cash pile of $440 M versus $30 M of debt, cash‑flow generation remains negative, and the 30‑day volatility of over 75% combined with a beta of 1.75 points to a highly volatile equity.
Recent shareholder letters highlight a three‑phase strategic plan aimed at unlocking long‑term value and note the pending sale of MarkForged to Stratasys, suggesting a possible asset‑light pivot. However, the ongoing Schedule 13D filing by Murchinson Strategic Alternatives adds uncertainty about future ownership and strategic direction. Given the confluence of bearish price action, weak earnings, high volatility, and an ambiguous strategic outlook, the stock presents a high‑risk, value‑oriented proposition at current levels.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below key moving averages
  • Negative earnings and cash‑flow
  • Elevated volatility and beta

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strategic plan rollout and asset sale potential
  • Strong cash cushion offsetting debt
  • Uncertain ownership dynamics from 13D filing

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Low price‑to‑book offering value upside
  • Potential turnaround from restructuring and divestitures
  • Long‑term growth prospects in additive manufacturing

Key Metrics & Analysis

Financial Health

Revenue Growth106.40%
Profit Margin-286.72%
P/E Ratio149.0
ROE-21.92%
ROA-7.29%
Debt/Equity6.27
P/B Ratio0.6
Op. Cash Flow$-100884000
Free Cash Flow$-55884376
Industry P/E36.8

Technical Analysis

TrendBearish
RSI38.7
Support$1.44
Resistance$1.85
MA 20$1.61
MA 50$1.69
MA 200$1.70
MACDBearish
VolumeStable
Fear & Greed Index89.86

Valuation

GradeFair
TypeValue

Risk Assessment

Beta1.75
Volatility75.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.